FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

David Daniel

Research Profile

Chemicals & Drugs

Disorders

Concepts & Ideas

Psychiatric Status Rating Scales

Procedures

Activities & Behaviors

Schizophrenic Psychology

Devices

Placebos

Co-author Network

Publications

TOP 3
David G Daniel; Glenn W Currier; Dan L Zimbroff; Michael Allen; Dan A Oren; George Manos; Robert D McQuade; Andrei Pikalov; David T Crandall
Efficacy and safety of oral aripiprazole compared with haloperidol in patients transitioning from acute treatment with intramuscular formulations.
Glenn W Currier; Michael Allen; E Bradshaw Bunney; David G Daniel; Andrew Francis; Andy S Jagoda; Dan L Zimbroff
Standard therapies for acute agitation.
Glenn W Currier; Michael Allen; E Bradshaw Bunney; David G Daniel; Andrew Francis; Andy S Jagoda; Dan L Zimbroff
Intramuscular antipsychotics: clinical experience review.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of David Daniel (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2007: David G Daniel; Glenn W Currier; Dan L Zimbroff; Michael Allen; Dan A Oren; George Manos; Robert D McQuade; Andrei Pikalov; David T Crandall
Efficacy and safety of oral aripiprazole compared with haloperidol in patients transitioning from acute treatment with intramuscular formulations.
Journal of psychiatric practice 2007;13(3):170-7.
2004: Glenn W Currier; Michael Allen; E Bradshaw Bunney; David G Daniel; Andrew Francis; Andy S Jagoda; Dan L Zimbroff
Standard therapies for acute agitation.
The Journal of emergency medicine 2004;27(4 Suppl):S9-12; quiz S7.
2004: Glenn W Currier; Michael Allen; E Bradshaw Bunney; David G Daniel; Andrew Francis; Andy S Jagoda; Dan L Zimbroff
Intramuscular antipsychotics: clinical experience review.
The Journal of emergency medicine 2004;27(4 Suppl):S3-4; quiz S8.
2004: Glenn W Currier; Michael Allen; E Bradshaw Bunney; David G Daniel; Andrew Francis; Andy S Jagoda; Dan L Zimbroff
Future directions in research.
The Journal of emergency medicine 2004;27(4 Suppl):S27-9.
2004: Glenn W Currier; Michael Allen; E Bradshaw Bunney; David G Daniel; Andrew Francis; Andy S Jagoda; Dan L Zimbroff
Updated treatment algorithm.
The Journal of emergency medicine 2004;27(4 Suppl):S25-6.
2004: Glenn W Currier; Michael Allen; E Bradshaw Bunney; David G Daniel; Andrew Francis; Andy S Jagoda; Dan L Zimbroff
Safety of medications used to treat acute agitation.
The Journal of emergency medicine 2004;27(4 Suppl):S19-24.
2004: Glenn W Currier; Michael Allen; E Bradshaw Bunney; David G Daniel; Andrew Francis; Andy S Jagoda; Dan L Zimbroff
Novel therapies for treating acute agitation.
The Journal of emergency medicine 2004;27(4 Suppl):S13-8.
2004: Alan C Swann; David G Daniel; Lisa D Kochan; Patricia Wozniak; Joseph Calabrese
Psychosis in mania: specificity of its role in severity and treatment response.
The Journal of clinical psychiatry 2004;65(6):825-9.
2004: Leslie Citrome; Daniel E Casey; David G Daniel; Patricia Wozniak; Lisa D Kochan; Katherine A Tracy
Adjunctive divalproex and hostility among patients with schizophrenia receiving olanzapine or risperidone.
Psychiatric services (Washington, D.C.) 2004;55(3):290-4.
2004: David G Daniel; Dan L Zimbroff; Rachel H Swift; Edmund P Harrigan
The tolerability of intramuscular ziprasidone and haloperidol treatment and the transition to oral therapy.
International clinical psychopharmacology 2004;19(1):9-15.
2003: Daniel E Casey; David G Daniel; Adel A Wassef; Katherine A Tracy; Patricia Wozniak; Kenneth W Sommerville
Effect of divalproex combined with olanzapine or risperidone in patients with an acute exacerbation of schizophrenia.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2003;28(1):182-92.
2001: David G Daniel; S G Potkin; KR Reeves; Rachel H Swift; Edmund P Harrigan
Intramuscular (IM) ziprasidone 20 mg is effective in reducing acute agitation associated with psychosis: a double-blind, randomized trial.
Psychopharmacology 2001;155(2):128-34.
1999: David G Daniel; Dan L Zimbroff; S G Potkin; KR Reeves; Edmund P Harrigan; M Lakshminarayanan
Ziprasidone 80 mg/day and 160 mg/day in the acute exacerbation of schizophrenia and schizoaffective disorder: a 6-week placebo-controlled trial. Ziprasidone Study Group.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1999;20(5):491-505.
1998: David G Daniel; Patricia Wozniak; RJ Mack; B G McCarthy
Long-term efficacy and safety comparison of sertindole and haloperidol in the treatment of schizophrenia. The Sertindole Study Group.
Psychopharmacology bulletin 1998;34(1):61-9.
1998: David G Daniel; S R Whitcomb
Treatment of the refractory schizophrenic patient.
The Journal of clinical psychiatry 1998;59 Suppl 1():13-9; discussion 20-1.
1997: Dan L Zimbroff; John M Kane; Carol A Tamminga; David G Daniel; RJ Mack; Patricia Wozniak; T B Sebree; B A Wallin; K B Kashkin
Controlled, dose-response study of sertindole and haloperidol in the treatment of schizophrenia. Sertindole Study Group.
The American journal of psychiatry 1997;154(6):782-91.